טוען...
Diabetic retinopathy and the use of laser photocoagulation: is it cost-effective to treat early?
BACKGROUND/AIMS: The aim of the study was to explore whether it would be cost-effective to apply panretinal photocoagulation (PRP) at the severe non-proliferative diabetic retinopathy (NPDR) (early treatment) stage, compared with waiting until high-risk proliferative diabetic retinopathy (HR-PDR) ch...
שמור ב:
| הוצא לאור ב: | BMJ Open Ophthalmol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5721644/ https://ncbi.nlm.nih.gov/pubmed/29354716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjophth-2016-000021 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|